Skip to main content
Piramal Pharma Limited (NSE:PPLPHARMA)
India flag India · Delayed Price · Currency is INR
179.85
-1.00 (-0.55%)
At close: Dec 5, 2025

Revenue by Product

Fiscal year is April - March.
Fiscal Year
 FY 2023 FY 2022 FY 2021
Period Ending
 Mar '23 Mar '22 Mar '21
Contract Development and Manufacturing Organisation
47.39B
Log In
Log In
Inhalation Anesthesia
16.42B
Log In
Log In
Inhalation Anesthesia Growth
13.25%
Log In
Log In
Intrathecal Therapy
3.68B
Log In
Log In
Intrathecal Therapy Growth
8.17%
Log In
Log In
Injectable Anesthesia and Pain Management
2.45B
Log In
Log In
Injectable Anesthesia and Pain Management Growth
-1.66%
Log In
Log In
Kids Wellness
2.26B
Log In
Log In
Kids Wellness Growth
20.63%
Log In
Log In
Other Generic and Specialty Products
1.96B
Log In
Log In
Other Generic and Specialty Products Growth
-13.46%
Log In
Log In
Skin Care
1.86B
Log In
Log In
Skin Care Growth
4.40%
Log In
Log In
Analgesic
1.86B
Log In
Log In
Multivitamin
1.47B
Log In
Log In
Other
2.35B
Log In
Log In
Other Growth
-51.42%
Log In
Log In
Commercial Manufacturing
-
Log In
Log In
Development Services
-
Log In
Log In
Discovery Services
-
Log In
Log In
Global Pharma
-
Log In
Log In
Over the Counter Products
-
Log In
Log In
Miscellaneous
-
Log In
Log In
Other
2.35B
Log In
Log In
Other Growth
-51.42%
Log In
Log In

Revenue by Geography

Fiscal year is April - March.
Fiscal Year
 FY 2023 FY 2022 FY 2021
Period Ending
 Mar '23 Mar '22 Mar '21
Other
8.17B
Log In
Log In
Other Growth
4.90%
Log In
Log In
North America
33.50B
Log In
Log In
North America Growth
5.13%
Log In
Log In
Europe
20.43B
Log In
Log In
Europe Growth
44.23%
Log In
Log In
India
16.34B
Log In
Log In
India Growth
15.39%
Log In
Log In
Japan
3.27B
Log In
Log In
Japan Growth
15.39%
Log In
Log In
Other
8.17B
Log In
Log In
Other Growth
4.90%
Log In
Log In